# Hypopharynx ICG to Reduce the Fistula Rate in Patients Undergoing Salvage Laryngectomy

> **NCT05350540** · PHASE2 · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 70 (estimated)

## Conditions studied

- Surgery Site Fistula

## Interventions

- **OTHER:** ICG dye

## Key facts

- **NCT ID:** NCT05350540
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-11
- **Primary completion:** 2028-11
- **Final completion:** 2028-11
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2022-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05350540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05350540, "Hypopharynx ICG to Reduce the Fistula Rate in Patients Undergoing Salvage Laryngectomy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05350540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*